Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Rogler

Showing results (81-90 of 134) with videos related to

Pageof 14
Sort By:
Gut|May 20, 2006
Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factorE Lippert, W Falk, F Bataille, et al.
Journal of Crohn'S & Colitis|March 12, 2020
Stromal Cells in the Pathogenesis of Inflammatory Bowel DiseaseM C Barnhoorn, S K Hakuno, R S Bruckner, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 17, 2004
Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cellsM Mühlbauer, B Allard, A K Bosserhoff, et al.
International Journal of Colorectal Disease|February 27, 2004
Interferon gamma downregulates IL-8 production in primary human colonic epithelial cells without induction of apoptosisK Schlottmann, F-P Wachs, J Grossmann, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2015
Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's diseaseE Safroneeva, S R Vavricka, N Fournier, et al.
Gut|June 14, 2005
Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn's diseaseK Schreiter, M Hausmann, T Spoettl, et al.
Zeitschrift Fur Gastroenterologie|May 29, 2015
[Current position on Vedolizumab for ulcerative colitis and Crohn's disease]S Schreiber, A U Dignass, H Hartmann, et al.
European Journal of Gastroenterology & Hepatology|November 27, 1998
Late onset primary oxalosis type I: an uncommon presentation of a rare diseaseT Glück, B K Krämer, C Zülke, et al.
Clinical and Experimental Immunology|May 8, 2008
(GT)N dinucleotide repeat polymorphism of haem oxygenase-1 promotor region is not associated with inflammatory bowel disease risk or disease courseM Hausmann, G Paul, S Kellermeier, et al.
Clinical and Experimental Immunology|September 14, 2006
Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivoK Menzel, M Hausmann, F Obermeier, et al.
Pageof 14

Showing results (81-90 of 134) with videos related to

Sort By:
Pageof 14
Gut|May 20, 2006
Soluble galectin-3 is a strong, colonic epithelial-cell-derived, lamina propria fibroblast-stimulating factorE Lippert, W Falk, F Bataille, et al.
Journal of Crohn'S & Colitis|March 12, 2020
Stromal Cells in the Pathogenesis of Inflammatory Bowel DiseaseM C Barnhoorn, S K Hakuno, R S Bruckner, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 17, 2004
Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cellsM Mühlbauer, B Allard, A K Bosserhoff, et al.
International Journal of Colorectal Disease|February 27, 2004
Interferon gamma downregulates IL-8 production in primary human colonic epithelial cells without induction of apoptosisK Schlottmann, F-P Wachs, J Grossmann, et al.
Alimentary Pharmacology & Therapeutics|August 15, 2015
Impact of the early use of immunomodulators or TNF antagonists on bowel damage and surgery in Crohn's diseaseE Safroneeva, S R Vavricka, N Fournier, et al.
Gut|June 14, 2005
Glycoprotein (gp) 96 expression: induced during differentiation of intestinal macrophages but impaired in Crohn's diseaseK Schreiter, M Hausmann, T Spoettl, et al.
Zeitschrift Fur Gastroenterologie|May 29, 2015
[Current position on Vedolizumab for ulcerative colitis and Crohn's disease]S Schreiber, A U Dignass, H Hartmann, et al.
European Journal of Gastroenterology & Hepatology|November 27, 1998
Late onset primary oxalosis type I: an uncommon presentation of a rare diseaseT Glück, B K Krämer, C Zülke, et al.
Clinical and Experimental Immunology|May 8, 2008
(GT)N dinucleotide repeat polymorphism of haem oxygenase-1 promotor region is not associated with inflammatory bowel disease risk or disease courseM Hausmann, G Paul, S Kellermeier, et al.
Clinical and Experimental Immunology|September 14, 2006
Cathepsins B, L and D in inflammatory bowel disease macrophages and potential therapeutic effects of cathepsin inhibition in vivoK Menzel, M Hausmann, F Obermeier, et al.
Pageof 14